Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control network

The aim of this study was to investigate the effect and possible mechanism of Astragaloside IV (AS-IV) on retarding the progression of diabetic nephropathy (DN) in a type 2 diabetic animal model, db/db mice. Eight-week-old male db/db diabetic mice and their nondiabetic littermate control db/m mice w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Liu, Xinhui, Wang, Wenjing, Song, Gaofeng, Wei, Xian, Zeng, Youjia, Han, Pengxun, Wang, Dongtao, Shao, Mumin, Wu, Juan, Sun, Huili, Xiong, Guoliang, Li, Shunmin
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5540580/
https://ncbi.nlm.nih.gov/pubmed/28767702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0182558
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky